This technical analysis of AbbVie (ABBV), published on August 27, 2025, identifies a robust short-term upward trend, estimating an 11.13% change over the upcoming three months with returns ranging from 3.58% to 13.2%. Long-term 12-month outlook predicts approximately 3.08% price appreciation with fluctuations between -15.74% and 8.88%, projecting a future price range of $175.31 to $226.53. The latest daily update on August 27, 2025, shows ABBV's stock price decreasing by 0.144%, fluctuating by 1.26% between a low of $207.81 and a high of $210.42, with a 3 million share volume. Our systems indicate undervaluation and ABBV as a 'Buy Candidate' with signals suggesting further declines until a new bottom pivot is found, a stop loss is suggested at $199.92. It emphasizes the significance of monitoring the upcoming earnings report for the third quarter of 2025.The report notes a recent insider purchase of 42,370 shares and a subsequent insider sale of the same amount.